CORC  > 山东大学
Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model
Liu, Xiangjuan; Xu, Qun; Wang, Xiaomeng; Zhao, Zhuo; Zhang, Liping; Zhong, Ling; Li, Li; Kang, Weiqiang; Zhang, Yun; Ge, Zhiming
刊名Pharmacological research: The official journal of The Italian Pharmacological Society
2015
页码43-51
关键词Diabetic cardiomyopathy Irbesartan Protein kinase D Endoplasmic reticulum stress
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4772233
专题山东大学
作者单位1.Shandong Univ, Qilu Hosp, Chinese Minist Educ, Key Lab Cardiovasc Remodeling & Funct Res, Jinan
2.Shandong Univ, Qilu Hosp, Ch
推荐引用方式
GB/T 7714
Liu, Xiangjuan,Xu, Qun,Wang, Xiaomeng,et al. Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model[J]. Pharmacological research: The official journal of The Italian Pharmacological Society,2015:43-51.
APA Liu, Xiangjuan.,Xu, Qun.,Wang, Xiaomeng.,Zhao, Zhuo.,Zhang, Liping.,...&Ge, Zhiming.(2015).Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model.Pharmacological research: The official journal of The Italian Pharmacological Society,43-51.
MLA Liu, Xiangjuan,et al."Irbesartan ameliorates diabetic cardiomyopathy by regulating protein kinase D and ER stress activation in a type 2 diabetes rat model".Pharmacological research: The official journal of The Italian Pharmacological Society (2015):43-51.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace